Finance

Lists
Why is VENUSREM up 4.02%?
Dive Deeper
VENUSREM:NSE
Venus Remedies Ltd
₹1,558.00
+4.02%
(+60.20) 1D
Nov 16, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VENUSREM...
Open
₹1,490.00
High
₹1,572.00
Low
₹1,478.30
Mkt. cap
20.91B
Avg. vol.
39.43K
Volume
49.80K
Dividend
0.64%
Quarterly dividend
₹2.50
Ex-dividend date
Aug 7, 2026
P/E ratio
17.11
52-wk high
₹2,044.30
52-wk low
₹550.00
EPS
₹91.05
Shares outstanding
12.34M
No. of employees
1K
Open
₹1,490.00
High
₹1,572.00
Low
₹1,478.30
Mkt. cap
20.91B
Avg. vol.
39.43K
Volume
49.80K
Dividend
0.64%
Quarterly dividend
₹2.50
Ex-dividend date
Aug 7, 2026
P/E ratio
17.11
52-wk high
₹2,044.30
52-wk low
₹550.00
EPS
₹91.05
Shares outstanding
12.34M
No. of employees
1K
News stories
From web sources and news partners
About Venus Remedies Ltd
CEOSaransh Chaudhary
Employees1.47K
Founded1989
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.80B
2.59B
1.79B
2.19B
Cost of goods sold
862.50M
1.22B
842.80M
1.06B
Cost of revenue
862.50M
1.22B
842.80M
1.06B
Research and development expenses
47.30M
51.03M
46.70M
59.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
517.60M
693.21M
557.20M
640.20M
Operating expense
630.50M
788.52M
671.60M
795.40M
Total operating expenses
1.49B
2.00B
1.51B
1.86B
Operating income
309.60M
589.89M
274.20M
329.60M
Other non operating income
25.20M
-54.65M
26.20M
5.10M
EBT including unusual items
334.70M
615.93M
300.40M
334.70M
EBT excluding unusual items
334.70M
556.56M
300.40M
334.70M
Income tax expense
78.90M
141.14M
70.70M
78.20M
Effective tax rate
23.57%
22.92%
23.54%
23.36%
Other operating expenses
-
-23.33M
-
-
Net income
255.80M
474.79M
229.70M
256.50M
Net profit margin
14.19%
18.30%
12.84%
11.73%
Earnings per share
-
-
-
-
Interest and investment income
-
21.39M
-
-
Interest expense
-100.00K
-67.00K
-
-
Net interest expenses
-100.00K
21.32M
-
-
Depreciation and amortization charges
65.60M
67.61M
67.70M
95.40M
EBITDA
358.59M
631.04M
338.38M
411.15M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps